FDA-approved HBOT Treatment for Various Conditions

These are conditions that have completed the necessary clinical trials demonstrating the proven success rates necessary to be a condition approved for HBOT therapy. Approved conditions are generally covered by insurance.

Conditions FDA approved for HBOT therapy are:

• Acute traumatic ischemias (crush injury, blast injuries, compartment syndrome)
• Anemia (due to acute blood loss)
• Carbon monoxide poisoning
• Clostridal myositis and myonecrosis (gas gangrene)
• Diabetically derived illnesses (foot ulcers, retinopathy, nephropathy)
• Decompression sickness
• Gas embolism (often from diving)
• Idiopathic sudden sensorineural hearing loss
• Intracranial abscess (acute brain infection from trauma or disease)
• Necrotizing fasciitis (flesh eating bacteria)
• Osteoradionecrosis / myoradionecrosis (radiation injury to soft tissue and bone)
• Radiation injury (delayed soft tissue and bone necrosis)
• Refractory osteomyelitis
• Retinal artery occlusion
• Skin grafts and flaps (compromised post operatively)
• Thermal burns